-
2 top biotech buyout candidates — SABCS news from AstraZeneca, Roche, Seattle Genetics — Correvio’s AFib drug can’t win over FDA panel — See more on our front page newsDismiss Notice
TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE -
Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.Dismiss Notice